Background
Long COVID has affected millions worldwide, with a disproportionate impact in high-risk communities due to social determinants of health (SDOH). Although stigma and provider dismissal are frequently described by Long COVID patients, few studies have systematically quantified healthcare-associated stigma or explored the intersection with SDOH and clinical severity. Understanding stigma is critical, as it may exacerbate health inequities, delay diagnosis, and reduce engagement in care.
Methods
The COVID-19 Persistence and Immunology Cohort (C-PIC) includes a binary survey question: “Have you experienced stigma or felt dismissed by healthcare providers regarding your Long COVID symptoms?” Healthcare-associated stigma was compared across demographic (age, gender, race, ethnicity, income, health insurance) and clinical variables (acute COVID severity, Long COVID severity, received Long COVID-specific care) using chi-squared and Fisher’s exact tests. Severe acute COVID was defined as requiring hospital admission and severe Long COVID as meeting criteria for myalgic encephalomyelitis/chronic fatigue syndrome.
Results
Among 401 C-PIC participants, 128 (30%) reported Long COVID healthcare-associated stigma at baseline. Prevalence was highest among White (46%) compared with multiracial (28%), Black (15%), and Asian (12%) (p<0.0001) participants. Rates were elevated in non-Hispanic participants (35% vs. 19%, p=0.004), history of severe acute COVID (55% vs. 30%, p=0.005), and severe Long COVID (60% vs. 10%, p<0.0001). Trends toward increased stigma were seen among participants with income >$80,000 (34%) and private health insurance (34%). Among 151 (38%) participants who sought Long COVID–specific care, 105 (70%) reported stigma, including 78% of White vs. 38% of Black participants (p=0.0007).
Conclusions
Healthcare-associated stigma was reported by nearly a third of participants, particularly among those with severe acute COVID and Long COVID, and those who received Long COVID-specific care. Notably, stigma was reported more often by White and non-Hispanic participants, in contrast to intersectional stigma patterns seen in other conditions such as HIV. This may reflect differing prior experiences with healthcare systems, communication dynamics, or expectations of care. These findings highlight the need for improved provider education, stigma-reduction interventions, and qualitative research to elucidate mechanisms and patient experiences underlying healthcare-associated stigma in Long COVID.